Claims 2025 Navigating an Increasingly Difficult and Complex World for Life Science Companies
Автор: Medmarc
Загружено: 2025-12-11
Просмотров: 14
In our annual end of year claims webinar, Andy Hall (Executive Claims Specialist—Medmarc) and Ricky C. Benjamin (Partner - Head of Life Sciences Industry Practice - Burr & Forman, LLP) gave an update on the claims and legal environment for life science companies. Topics discussed included:
• GLP-1s and compounding pharmacies;
• Laboratory developed tests and legal challenges over their regulation;
• An update on Loper Bright and outside entities’ ability to challenge administrative decisions;
• The admissibility of 510(k) evidence in life science matters; and
• An update on important verdicts and legal decisions.
Which topic most intrigued you? Let us know!
00:00 - Introduction of the Presenters
03:11 - Admissibility of 510(k) evidence
12:04 - GLP-1s? Wonder drug? Litigation target? Both?
26:27 - Loper Bright—A year later
32:48 - Recent developments with LDTs
47:05 - Autism and Tylenol—still a litigation issue?
54:50 - Closing
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
